Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 100.3K | 89.7K | 87.7K | 158.9K |
Other operating expenses | — | — | — | — |
Operating income | -100.3K | -89.7K | -87.7K | -158.9K |
Non operating interest income | ||||
Income | 0 | 0 | 96 | 38 |
Expense | — | — | — | 172.2K |
Other income expense | -1 | — | — | -11.0M |
Pretax income | -100.3K | -89.7K | -87.6K | -11.4M |
Tax provision | — | — | — | — |
Net income | -100.3K | -89.7K | -87.6K | -11.4M |
Basic EPS | 0.0 | 0.0 | 0.0 | — |
Diluted EPS | 0.0 | 0.0 | 0.0 | — |
Basic average shares | 9.3M | 9.3M | 9.3M | — |
Diluted average shares | 9.3M | 9.3M | 9.3M | — |
EBITDA | -100.3K | -89.7K | -87.7K | -158.8K |
Net income from continuing op. | -100.3K | -89.7K | -87.6K | -11.4M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |